Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen

Trial Profile

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Uterine diseases
  • Focus Therapeutic Use
  • Acronyms IMPROVE
  • Most Recent Events

    • 08 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 10 May 2016 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
    • 10 May 2016 Planned primary completion date changed from 1 Dec 2019 to 1 Jul 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top